TroostplekDe internet rustplaats

In memoriam · condoleanceregister

Tim Crow

ook bekend als Tim Crow

Geboren
7 juni 1938
Overleden
10 november 2024
Leeftijd
86 jaar
Rustplaatsen
Wetenschappers & uitvinders Bekende mensen, Verenigd Koninkrijk Landen

Biografie

Timothy John Crow, (7 June 1938 – 10 November 2024) was a British psychiatrist and researcher. Much of his research was related to finding the causes of schizophrenia. He also had an interest in neurology and evolutionary theory. He was the Honorary Director of the Prince of Wales International Centre for Research into Schizophrenia and Depression. He qualified at the Royal London Hospital in 1964 and obtained a PhD at the University of Aberdeen, Scotland in 1970. He was a Fellow of the Royal College of Physicians, the Royal College of Psychiatrists and the Academy of Medical Sciences. Crow was, for twenty years, Head of the Division of Psychiatry of the Medical Research Council (MRC) Clinical Research Centre at Northwick Park Hospital and then a member of the External Scientific Staff of the MRC in Oxford.

Research

Neurobiology of reinforcement and motivation

Crow worked in the Department of Physiology at the University of Aberdeen in the late 1960s and early 1970s, where he conducted pharmacological and behavioural studies of reinforcement and self-stimulation in rats for his Medical Research Council funded PhD: "Experiments on the central actions of the amphetamines with particular reference to the functions of catecholamine-containing neurones". He published a number of papers dissecting the role of the various catecholamines in reinforcement and motivation, and in 1973 was the first person to publish an article arguing for a key role for the neurotransmitter dopamine in 'incentive motivation'. Crow's role as the first scientist to link dopamine to incentive motivation has been acknowledged by Berridge and by Robbins and Everitt.

Psychosis and schizophrenia

In 1978 Crow, in conjunction with his colleague Eve Johnstone and others, showed that the anti-psychotic drug, flupentixol, reduced the severity of schizophrenic delusions specifically because of its action on the neurotransmitter dopamine. Johnstone, Crow and colleagues were also the first to demonstrate, by randomised double-blind clinical trials, that electroconvulsive therapy (ECT) could reduce the symptoms of endogenous depression, albeit over a short time period. This finding has been substantially replicated in many other settings.

Crow's long term research interests were in the nature and causation of the major psychoses. These illnesses are characterised by the presence of delusions, hallucinations, and disorders of thinking that generally start in early and middle adult life. Encompassing schizophrenia and manic-depressive psychosis, these disorders are common, being diagnosed in around 2% of the population in the course of a lifetime, but with wide cultural variation.

In the first CT scan study in 1976 Crow and colleagues at Northwick Park Hospital demonstrated that there are, across groups, structural differences in the brain (e.g. a degree of enlargement of the cerebral ventricles) in individuals who have suffered from schizophrenia compared to healthy people. Much subsequent work with MRI scans and in post-mortem brain studies has confirmed this, suggesting that the differences are in the cerebral cortex and are particularly related to the subtle asymmetries that are characteristic of the human cortex. Crow also demonstrated that people with schizophrenia show less left-sided cerebral dominance for some components of language.

In the 1980s, Crow published an article, focusing on the classification of the symptoms of the disease rather than focusing on the cluster of symptoms in individual patients, that became a breakthrough in the field of research on schizophrenia. He also introduced the idea of two syndromes of schizophrenia one based on positive symptoms and the other on negative symptoms, which contributed to an understanding of the cognitive nature of schizophrenia.

In 1989, Crow was awarded the Lieber Prize for Outstanding Achievement In Schizophrenia Research. In a retrospective review of 20 years of evidence of neurodevelopmental abnormalities in the brains of people with schizophrenia, Sir Robin Murray described the work of Johnstone and Crow on ventricular enlargement and negative symptoms in psychosis as being widely regarded by British psychiatrists as ‘marking the beginning of modern schizophrenia research’.

Psychosis and Human Evolution

Based on the supposition that language and psychosis are specifically human conditions, Crow spent his later career investigating the implications for schizophrenia of the occurrence of cerebral asymmetry in humans but not chimpanzees. Further work on handedness, heritability of psychosis, sex differences in age of onset in schizophrenia, and genes on the sex chromosomes in schizophrenia contributed to a large, but as yet unresolved, body of work on the contribution of the sex chromosomes, to brain development and function, including propensity to schizophrenia.

Death

Crow died from complications of Parkinson's disease on 10 November 2024, at the age of 86.

Bron: Wikipedia, beschikbaar onder de licentie CC BY-SA 4.0.

In Memoriam weblink

en.wikipedia.org/wiki/Tim_Crow

Foto's

Medeleven en bloemen 0

Het condoleanceregister van Tim Crow: betuig hieronder uw medeleven aan de nabestaanden, leg een bloem of steek een kaars aan.

  • TroostplekSterkte aan alle nabestaanden.

Betuig als eerste uw medeleven of leg een bloem.

Uw medeleven of een bloem

Wat wilt u plaatsen?
Hoe lang is uw bericht?
Kies een bloem

Alle 27

Rouwkransen 4

Rouwboeketten 3

Klassiek 20

Hoe lang blijft uw bloem liggen?

Vaker een bloem leggen? Word lid: dan legt u zoveel bloemen als u wilt, en ze blijven allemaal voor altijd liggen. € 6,00 per maand of € 60,00 per jaar. Lid worden (met een gratis account)

0 / 500 tekens

Troostplek is een plek om te gedenken. Berichten worden eerst gelezen en daarna geplaatst; berichten die daar niet passen, verwijderen wij zonder uitleg.

Uw bloem voor altijd laten liggenEen langer medeleven plaatsen

€ 3,95€ 3,45 eenmalig

  • Uw bloem wordt nu gelegd en is meteen te zien.
  • Zodra uw betaling binnen is, blijft hij voor altijd liggen.
  • Lukt het betalen niet, dan blijft hij een maand liggen, zoals een gratis bloem.
  • Uw medeleven wordt nu geplaatst. Tot uw betaling binnen is, zijn alleen de eerste 500 tekens te lezen.
  • Zodra uw betaling binnen is, is de hele tekst te lezen.
  • Liever gratis? Ga terug en maak uw bericht korter dan 501 tekens.
Hoe wilt u betalen?

Bij crypto betaalt u de transactiekosten van het netwerk zelf, bovenop het bedrag. Bij iDEAL en een bankoverschrijving zijn er geen extra kosten.

Bij een bankoverschrijving of crypto ziet u na het plaatsen hoe u betaalt. Vul uw e-mailadres in om dat ook per mail te krijgen.

Vaker een bloem leggen? Als lid legt u zoveel bloemen als u wilt, voor altijd, vanaf € 6,00 per maand.Vaker een langer bericht? Als lid schrijft u zo lang als u wilt, gratis, vanaf € 6,00 per maand. Lid worden

Melden

Past dit bericht of deze bloem niet op Troostplek? Na uw melding is het niet meer te zien, tot wij ernaar hebben gekeken.

Meld een fout of aanvulling

Over het register van Tim Crow. Vul in wat er anders moet; de rest mag leeg blijven.

Nu: Tim Crow

Nu: 7 juni 1938

Nu: 10 november 2024

Nu: Wetenschappers & uitvinders